Silodosin PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Silodosin PCD pharma franchise company in India, offering a focused range of 9 Silodosin formulations across capsules and tablets. Every batch is produced at WHO-GMP certified facilities with DCGI-approved compositions, giving franchise partners a urology product line they can promote with confidence.
What is Silodosin?
Silodosin is a highly uroselective alpha-1A adrenoceptor antagonist. By blocking alpha-1A receptors concentrated in the prostate and bladder neck, it relaxes smooth muscle and eases urine flow, which is why it is used to treat the lower urinary tract symptoms of benign prostatic hyperplasia (BPH). Its selectivity for the alpha-1A subtype means it has comparatively little effect on vascular alpha-1B receptors. Detailed pharmacological data is available on PubChem.
Therapeutic Applications of Silodosin
Silodosin is indicated for the management of signs and symptoms of benign prostatic hyperplasia, including hesitancy, weak stream, urgency, frequency and incomplete bladder emptying. It is also used as part of medical expulsive therapy protocols for distal ureteric stones in some settings. Prescriptions come principally from urologists, supported by consulting physicians, geriatricians and general surgeons who see ageing male patients.
Why Silodosin is a High-Potential Molecule for Distributors
BPH is an age-linked condition, and India's over-60 male population is expanding rapidly, so the prescription base for Silodosin grows every year rather than fluctuating seasonally. Its uroselectivity gives urologists a reason to prefer it over older alpha blockers in patients already on antihypertensives, and because BPH therapy is continued for months or years, a single patient converts into repeat monthly demand. For a distributor, that means a predictable, non-seasonal reorder cycle from a small number of high-value urology prescribers.
Why Choose Cafoli Lifecare
Cafoli Lifecare appoints franchise partners on a genuine district monopoly basis, so you never compete with another Cafoli distributor in your territory. Our products are manufactured in WHO-GMP certified units with DCGI-approved compositions, backed by full promotional inputs such as visual aids, MR bags, prescription pads, samples and doctor gifts. More than 1000+ partners across India already work with us.
References
- PubChem – Silodosin compound record
- MedlinePlus – Silodosin drug information
- PubMed – clinical literature on Silodosin
Our formulations of Silodosin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: